SBIR-STTR Award

Rapid, noninvasive Diagnosis and Monitoring of Shock
Award last edited on: 10/6/20

Sponsored Program
STTR
Awarding Agency
NIH : NHLBI
Total Award Amount
$162,065
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Donald Sanderson Prough

Company Information

Noninvasix Inc

1700 Strand Street Suite 1200
Galveston, TX 77555
   (409) 539-2230
   info@noninvasix.com
   www.noninvasix.com

Research Institution

University of Texas - Galveston

Phase I

Contract Number: 1R41HL103095-01
Start Date: 8/1/10    Completed: 6/30/11
Phase I year
2010
Phase I Amount
$162,065
Assessment and management of circulatory shock in critically ill patients requires rapid measurement of two critical variables: mixed venous oxyhemoglobin saturation (venous SO2) and total blood hemoglobin concentration [Hgb] to identify insufficient oxygen delivery and anemia and to determine the need for therapy with fluids, inotropic or vasodilator drugs or blood transfusion. Current invasive techniques for measurement of venous SO2 and [Hgb] require central venous or pulmonary arterial catheterization and blood sampling. In emergency department patients with septic shock, management based on maintaining venous SO2 at e 70%, as measured invasively in the superior vena cava, reduced mortality from 46.5% to 30.5%. At present, no available noninvasive technique measures venous SO2 and [Hgb] to guide treatment. Our research team has pioneered optoacoustic imaging techniques for accurate, non-invasive, real-time measurement of SO2 and [Hgb]. We designed, built, and performed in vitro and in vivo testing of a novel, compact, high-resolution optoacoustic imaging system that measures SO2 and [Hgb] directly from blood vessels. The optoacoustic imaging is based on generation of ultrasonic (optoacoustic) waves by near infra-red laser light pulses and detection of optoacoustic waves by a sensitive wide-band acoustic transducer. Optoacoustic waves are linearly dependent on SO2 and [Hgb]. Our in vitro and in vivo tests of the system with optoacoustic probes demonstrated that the system is capable of measuring oxygenation and [Hgb] measurement with high accuracy approaching that of the CO-Oximeter, the conventional gold standard method for measuring oxygen saturation in blood. In this application, our multidisciplinary team of bioengineers and intensivists proposes to develop and test novel, highly-portable clinical, prototype with unique capabilities for rapid, noninvasive assessment and management of circulatory shock in surgical and critically ill patients.

Public Health Relevance:
The proposed project will have a substantial impact on care of patients undergoing surgery, critically ill patients, and patients in shock. The proposed optoacoustic system will replace invasive, intermittent diagnostic testing of central venous blood oxygenation hemoglobin with noninvasive, rapid, and continuous monitoring.

Thesaurus Terms:
"acceleration; Accident And Emergency Department; Acoustic; Acoustics; Amplifiers; Anemia; Animals; Au Element; Biomedical Engineering; Blood; Blood Pressure; Blood Sample; Blood Transfusion; Blood Vessels; Blood Specimen; Businesses; Cathetergram; Catheterization; Catheterization, Central Venous; Catheters; Cell Communication And Signaling; Cell Signaling; Central Catheterization; Central Venous Catheterization; Chronotropism, Cardiac; Chronotropisms, Cardiac; Circulatory Collapse; Clinical; Clinical Evaluation; Clinical Testing; Collaborations; Consult; Critical Care; Critical Illness; Critically Ill; Detection; Development; Devices; Diagnosis; Diagnosis, Ultrasound; Diagnostic Tests; Echography; Echotomography; Electromagnetic, Laser; Emergency Department; Emergency Room; Emergent Technologies; Emerging Technologies; Environment; Fda; Feedback; Figs; Figs - Dietary; Food And Drug Administration; Food And Drug Administration (U.S.); Funding; Generations; Goals; Gold; Grant; Heart Rate; Hemoglobin; Hemorrhagic Shock; Image; Imaging Procedures; Imaging Techniques; In Vitro; Intensive Care; Internal Jugular Vein; Internal Jugular Vein Structure; Intracellular Communication And Signaling; Laboratories; Lasers; Light; Liquid Substance; Lung; Measurement; Measures; Medical; Medical Imaging, Ultrasound; Methods; Methods And Techniques; Methods, Other; Microprocessor; Monitor; Mortality; Mortality Vital Statistics; News; News (Pt); News [publication Type]; O Element; O2 Element; Operating Rooms; Operation; Operative Procedures; Operative Surgical Procedures; Optics; Output; Oxygen; Oxyhemoglobin; Patient Care; Patient Care Delivery; Patients; Phase; Photoradiation; Physicians; Physiologic Pulse; Plant Embryos; Predictive Value; Press Releases; Press Releases (Pt); Programs (Pt); Programs [publication Type]; Pulse; Radiation, Laser; Research; Resolution; Respiratory System, Lung; Resuscitation; Reticuloendothelial System, Blood; Secure; Seeds; Septic Shock; Services; Shock; Signal Transduction; Signal Transduction Systems; Signaling; Structure Of Subclavian Vein; Subclavian Vein; Superior Vena Cava Structure; Surgical; Surgical Interventions; Surgical Procedure; System; System, Loinc Axis 4; Technics, Imaging; Techniques; Testing; Texas; Time; Transducers; Usfda; Ultrasonic; Ultrasonic Imaging; Ultrasonics; Ultrasonogram; Ultrasonography; Ultrasound Test; Ultrasound, Medical; United States Food And Drug Administration; Universities; Vasodilating Agent; Vasodilator Agents; Vasodilator Drugs; Vasodilators; Vena Cava, Superior; Venous; Zygotes, Plant; Base; Bioengineering; Bioengineering/Biomedical Engineering; Biological Signal Transduction; Circulatory Shock; Clinical Test; Commercialization; Design; Designing; Diagnostic Ultrasound; Engineering Design; Evaluation/Testing; Fluid; Imaging; In Vivo; Liquid; Mental State; Multidisciplinary; News; Noninvasive Diagnosis; Novel; Programs; Prototype; Public Health Relevance; Pulmonary; Rapid Method; Rapid Technique; Research Clinical Testing; Seed; Septic; Sonogram; Sonography; Sound Measurement; Surgery; Ultrasound; Ultrasound Imaging; Ultrasound Scanning; Vascular"

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----